GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Scaled Net Operating Assets

Hemagen Diagnostics (Hemagen Diagnostics) Scaled Net Operating Assets : 0.56 (As of Sep. 2012)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hemagen Diagnostics's operating assets for the quarter that ended in Sep. 2012 was $2.38 Mil. Hemagen Diagnostics's operating liabilities for the quarter that ended in Sep. 2012 was $0.97 Mil. Hemagen Diagnostics's Total Assets for the quarter that ended in Jun. 2012 was $2.52 Mil. Therefore, Hemagen Diagnostics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2012 was 0.56.


Hemagen Diagnostics Scaled Net Operating Assets Historical Data

The historical data trend for Hemagen Diagnostics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Scaled Net Operating Assets Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.53 0.66 0.54 0.49

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.59 0.62 0.57 0.56

Competitive Comparison of Hemagen Diagnostics's Scaled Net Operating Assets

For the Biotechnology subindustry, Hemagen Diagnostics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Scaled Net Operating Assets falls into.



Hemagen Diagnostics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hemagen Diagnostics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2012 is calculated as

Scaled Net Operating Assets (SNOA)(A: Sep. 2012 )
=(Operating Assets (A: Sep. 2012 )-Operating Liabilities (A: Sep. 2012 ))/Total Assets (A: Sep. 2011 )
=(2.377-0.973)/2.888
=0.49

where

Operating Assets(A: Sep. 2012 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.443 - 0.066
=2.377

Operating Liabilities(A: Sep. 2012 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6 - 4.05 - 0.977
=0.973

Hemagen Diagnostics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2012 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2012 )
=(Operating Assets (Q: Sep. 2012 )-Operating Liabilities (Q: Sep. 2012 ))/Total Assets (Q: Jun. 2012 )
=(2.377-0.973)/2.521
=0.56

where

Operating Assets(Q: Sep. 2012 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.443 - 0.066
=2.377

Operating Liabilities(Q: Sep. 2012 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6 - 4.05 - 0.977
=0.973

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemagen Diagnostics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines